Sergio Barreto

Sergio Barreto

Sergio Barreto is about 70% journalist, 30% tech geek. As an editor for The ABIS Group, he produces daily newsletters for leading healthcare and technology companies. With BMV Digital, he provides WordPress-based web developments services. Here at Alternatives Watch, he wears both hats - handling IT and occasionally writing about the intersection of alts, healthcare and tech.
Private Equity

Alts Watch Healthcare Beat: Nearly $1bn in fresh capital flows in latest life sciences deals

In numerical terms, our latest recon of private market investment in the life sciences is about on par with the…

Read More »
Featured

Biotech, medtech ring in the holidays with $868m in private market deals

If anything could put a damper on the red-hot private market activity in healthcare, the Thanksgiving holiday did — so…

Read More »
Private Equity

AW healthcare beat: $1.4bn in biotech/medtech deal making

One deal towers above the rest in our look at the $1.41 billion private capital activity in healthcare for the…

Read More »
Private Equity

Introducing the Alts Watch healthcare Beat

No, you're not imagining it: private equity investment in healthcare has been on the rise. In fact, Pitchbook data shows…

Read More »
Private Equity

OrbiMed, Wellington backers of Chinese biotech Gracell

Wellington Management Company and Morningside Ventures joined healthcare investment specialists OrbiMed and Vivo Capital to lead a $100 million Series…

Read More »
Featured

Alts filling a huge gap for Brazilian family offices

When Daniel Rummery co-founded the Latin America-focused advisory and capital placements firm Brunel Partners, his adopted country — Brazil —…

Read More »
Endowments and Foundations

Mubadala cements cautious life sciences approach with $235m Evotec investment

Mubadala Investment Company agreed to acquire €200 million (US$235 million) worth of Hamburg-based Evotec shares in a private placement, giving…

Read More »
Hedge Funds

Hedge funds help biotech pioneer Palleon raise $100m

Hedge fund Matrix Capital Management led a $100 million Series B round for Palleon Pharmaceuticals, a leader in the emerging…

Read More »
Featured

General Atlantic backs emerging market payments platform dLocal

While investors and tech watchers were busy marveling at Klarna’s new $10.65 billion valuation, another emerging payments industry player was…

Read More »
Private Equity

PE powers cancer-focused Neogene’s Series A to $110m

In the latest example of the life science sector's appeal to alt players, T-cell therapy specialist Neogene Therapeutics raised $110…

Read More »
Back to top button